Výsledky vyhledávání - "V.V. Makashova"

Outcomes of chronic hepatitis C depending on patients’ age

Autor: S.V. Shabalina, V.V. Makashova, Zh.B. Ponezheva, Human Wellbeing, Moscow, Russian Federation, Kh.G. Omarova, I.V. Mannanova, N.T. Shapieva

Publikováno v: Infekcionnye bolezni. 19:105-109

In this review, we analyze the dynamics of the formation of liver cirrhosis (LC) and hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (CHC) with the consideration of age category and special attention paid to elderly patients. It w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c68577a03bde1f1c08259d1c62bfdefb
https://doi.org/10.20953/1729-9225-2021-1-105-109

Zobrazit plný text záznamu

Clinical and laboratory characteristics of patients with chronic hepatitis C and severe interferon system suppression

Autor: Zh.B. Ponezheva, I.V. Mannanova, S.V. Shabalina, V.V. Makashova, A.A. Erovichenkov, Human Wellbeing, Moscow, Russian Federation, A.V. Gorelov

Publikováno v: Infekcionnye bolezni. 19:60-64

Objective. To identify specific clinical and laboratory characteristics of patients with chronic hepatitis C (CHC) and severe interferon (IFN) system suppression. Patients and methods. This study was conducted at the Clinical Department of Infectious

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c001423275daf86322bc052d5e80db5f
https://doi.org/10.20953/1729-9225-2021-2-60-64

Zobrazit plný text záznamu

A modern view of the immunopathogenesis of chronic hepatitis B

Autor: Khokhlova O.N. Khokhlova O, Human Well-Being, Moscow, Russia, Omarova Kh.G. Omarova, Ponezheva Zh.B. Ponezheva, Makashova V.V. Makashova

Publikováno v: Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy. :73-79

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b66c574c08cd87484fe4345b9a841c14
https://doi.org/10.18565/epidem.2020.10.4.73-79

Zobrazit plný text záznamu

Experience with narlaprevir in the treatment of chronic hepatitis C

Autor: Ivanova M.R. Ivanova, Makashova V.V. Makashova, Titorenko M.V. Titorenko, Ponezheva Zh.B. Ponezheva, Patlusov E.V. Patlusov, Mannanova I.V. Mannanova, Kambieva L.F. Kambieva L, Sannikova I.V. Sannikova

Publikováno v: Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy. :76-83

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ed4e8fba3611dfe9506cea8de9f61f2
https://doi.org/10.18565/epidem.2020.10.2.7.76-83

Zobrazit plný text záznamu

Association between the duration of hepatitis C and activity and stage of liver fibrosis

Autor: A.V. Tutelyan, V.V. Makashova, Human Wellbeing, Moscow, Russian Federation, S.V. Shabalina

Publikováno v: Infekcionnye bolezni. 18:56-61

Objective: to assess the impact of the time of hepatitis C infection on the probability of liver fibrosis (according to epidemiological and immunological parameters). Patients and methods. This study was performed at the Clinical Department of Infect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b8775d71156ec158a319391eea42bc5c
https://doi.org/10.20953/1729-9225-2020-3-56-61

Zobrazit plný text záznamu

Chronic hepatitis B in a woman with chronic kidney disease

Autor: Kh.G. Omarova, Human Well-Being, Moscow, Russian Federation, Llc 'SM–Clinic', Moscow, Russian Federation, V.V. Makashova

Publikováno v: Russian Medical Inquiry. 4:710-713

A 38-year-old woman was diagnosed with phase 2 chronic hepatitis B without delta-agent (HBeAg+) with a high biochemical and viral load and significant liver fibrosis (F2) five years after renal allotransplantation for a chronic kidney disease stage 5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bce50472cb609bfa03350d75f37c7988
https://doi.org/10.32364/2587-6821-2020-4-11-710-713

Zobrazit plný text záznamu

Treatment with the first Russian direct-acting antiviral drug in patients with chronic hepatitis C

Autor: Human Well-Being, Moscow, Russia, Makashova V.V. Makashova, Ponezheva Zh.B. Ponezheva

Publikováno v: Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy. :77-83

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f366bdfe350595dbb66bb72cef94045e
https://doi.org/10.18565/epidem.2019.9.4.77-83

Zobrazit plný text záznamu

New areas in therapy for chronic hepatitis B

Autor: Human Well-Being, Moscow, Russia, Makashova V.V. Makashova, Omarova Kh.G. Omarova

Publikováno v: Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy. :84-91

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f7702254741e2944440f0d17ce18b7f5
https://doi.org/10.18565/epidem.2019.9.3.84-91

Zobrazit plný text záznamu

Immunological changes in patients with chronic hepatitis C who received direct-acting antiviral therapy

Autor: L.A. Ivanova, A.R. Reizis, V.V. Pokrovskiy, Human Wellbeing, Moscow, Russian Federation, O.N. Khokhlova, T.S. Nikitina, V.V. Makashova

Publikováno v: Infekcionnye bolezni. 17:33-38

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::67a106b5ddfd216d3a6c7e5f4e31667f
https://doi.org/10.20953/1729-9225-2019-1-33-38

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání